The Prescription Drug Transparency and Affordability Council, established in HB 166, is tasked with providing recommendations to the General Assembly, Governor DeWine, and the Joint Medicaid Oversight Committee regarding Ohio's best path forward for issues such as prescription drug price transparency, affordable payment models, and health care efficiency. The council is required to submit its report by June 30.

Council members:

• Matt Damschroder, Director, Ohio Department of Administrative Services
• Dr. Amy Acton, Director, Ohio Department of Health
• Maureen Corcoran, Director, Ohio Department of Medicaid
• Lori Criss, Director, Ohio Department of Mental Health and Addiction Services
• Stephanie McCloud, Administrator, Ohio Bureau of Workers’ Compensation
• Steve Ferris, Discount Drug Mart
• Ryan Augsburger, Ohio Manufacturers’ Association
• Holly L. Pendell, National Multiple Sclerosis Society
• James Flynn, Managing Partner, Bricker & Eckler
• Latoya Peterson, Associate State Director for Advocacy, AARP
• Mark Totman, Vice President, International Union of Operating Engineers
• The Honorable Christina Muryn, Mayor of Findlay, Ohio
• Pat Tiberi, President and CEO, Ohio Business Roundtable

Meetings: 

• Wednesday, Feb. 26, 2020: Welcome and general overview 
  • Agenda
  • National Governors Association Health Overview
  • Understanding the Prescription Drug Supply and Financing Chain
     
• Wednesday, May 27, 2020: Virtual meeting from 11 a.m. to noon
  • Meeting video
  • Agenda
  • ​Rational Drug Therapy Program presentation
  • New Jersey Reverse Auction presentation
     
• Monday, June 15, 2020: A virtual meeting will be held, time to be determined.

To subscribe to receive notices regarding the meetings, email Mariah Halleck at Mariah.Halleck@das.ohio.gov.